Literature DB >> 16990777

Elevated levels of serum CD44 and E-cadherin predict an unfavourable outcome in myelodysplastic syndromes.

J Loeffler-Ragg, M Steurer, H Ulmer, S Skvortsov, B Kircher, M Herold, H Zwierzina, R Stauder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16990777     DOI： 10.1038/sj.leu.2404382

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

Authors:  Niklas Mueller; Daniel Wicklein; Gregor Eisenwort; Mohamad Jawhar; Daniela Berger; Gabriele Stefanzl; Georg Greiner; Alexandra Boehm; Christoph Kornauth; Leonhard Muellauer; Susanne Sehner; Gregor Hoermann; Wolfgang R Sperr; Philipp B Staber; Ulrich Jaeger; Johannes Zuber; Michel Arock; Udo Schumacher; Andreas Reiter; Peter Valent
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

2.  The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.

Authors:  Suchismita Daw; Sujata Law
Journal:  Mol Cell Biochem       Date:  2020-10-04       Impact factor: 3.396

3.  Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.

Authors:  Cheng-Ming Fei; Juan Guo; You-Shan Zhao; Si-Da Zhao; Qing-Qing Zhen; Lei Shi; Xiao Li; Chun-Kang Chang
Journal:  J Transl Med       Date:  2018-08-24       Impact factor: 5.531
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.